Kalbe Farma Tbk PT
IDX:KLBF
Kalbe Farma Tbk PT
Cash
Kalbe Farma Tbk PT
Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Cash
Rp1.6T
|
CAGR 3-Years
-17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
12%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Cash
Rp64.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
23%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Cash
Rp437.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
42%
|
CAGR 10-Years
26%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Cash
Rp470.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Cash
Rp505.4B
|
CAGR 3-Years
129%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
70%
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Cash
Rp504.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
13%
|
|
Kalbe Farma Tbk PT
Glance View
Kalbe Farma Tbk PT is a renowned pharmaceutical powerhouse rooted in Indonesia, rooted in a rich history that traces back to 1966. The company has evolved from a humble startup into a multifaceted entity with a robust portfolio, making it a vital player in the health and wellness sector across Southeast Asia. The company operates across four main business divisions: prescription pharmaceuticals, consumer health products, nutritionals, and distribution & logistics. By strategically linking these divisions, Kalbe Farma masterfully balances scientific innovation with market accessibility, ensuring a wide reach and varied product offering. This diversification not only broadens its revenue streams but also mitigates risk, securing its foothold in the competitive pharmaceutical landscape. At the core of Kalbe Farma’s business model lies a commitment to research and development, which fuels its cutting-edge product innovations and enhances its competitive edge. The company dedicates substantial resources to developing new medicines and health products, constantly seeking to address emerging health concerns. Moreover, its extensive distribution network fortifies its market presence, comprising a domestic distribution arm that penetrates even the farthest reaches of the Indonesian archipelago. This network ensures that Kalbe's products are widely available, amplifying their market penetration and revenue. Additionally, Kalbe embraces partnerships and collaborations to enhance its research capabilities and expand its product offerings, fostering an ecosystem where innovation and accessibility coexist harmoniously, thereby empowering its bottom line.
See Also
What is Kalbe Farma Tbk PT's Cash?
Cash
1.6T
IDR
Based on the financial report for Sep 30, 2024, Kalbe Farma Tbk PT's Cash amounts to 1.6T IDR.
What is Kalbe Farma Tbk PT's Cash growth rate?
Cash CAGR 10Y
12%
Over the last year, the Cash growth was 27%. The average annual Cash growth rates for Kalbe Farma Tbk PT have been -17% over the past three years , 11% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet